Selected Grants
Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP) UX023-CL401
ResearchPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2018 - 2028Characterizing neurocognitive symptoms in older adults with primary hyperparathyroidism
ResearchCollaborator · Awarded by National Institutes of Health · 2023 - 2025Clinical indicators for early bone loss in Common Variable Immunodeficiency
ResearchCollaborator · Awarded by Immune Deficiency Foundation · 2019 - 2020A Phase 2 Open-Label Trial to Assess the Efficacy and Safety of KRN23, an Antibody to FGF23, in Subjects with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Clinical TrialPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2015 - 2019A Phase 2b, Open-Label, Long-Term Extension Study to Evaluate the Safety and Pharmacodynamics of KRN23 in Adult Subjects with X-Linked Hypophosphatemia (XLH)
Clinical TrialPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2015 - 2019A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of KRN23 in Adult Patients with X-linked Hypophosphatemia (XLH)¿
Clinical TrialPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2015 - 2019An Open-Label, Single-Arm, Phase 3 Study to Evaluate the Effects of KRN23 on Osteomalacia in Adults with X-Linked Hypophosphatemia (XLH)
Clinical TrialPrincipal Investigator · Awarded by Ultragenyx Pharmaceutical · 2015 - 2017HIV and Asthma in the Post- ART Era
ResearchConsultant · Awarded by National Institutes of Health · 2014 - 2016Clinically vs. pathologically negative lymph nodes in patients with papillary thyroid cancer: survival, radioactive iodine therapy and lymphadenectomy patterns of use
FellowshipMentor · Awarded by Endocrine Fellows Foundation · 2015 - 2016External Relationships
- AgNovos Healthcare
- Food and Drug Administration
- International Society of Clinical Densitometry
- Kyowa Hakko Kirin Pharma, Inc.
- Soft Bones, Inc
- The Endocrine Society
- Ultragenyx
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.